SEC Form 4 · accession 0001209191-18-041916
KYNTRA BIO, INC. · KYNB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James A Schoeneck
Director
Period of report
Jul 3, 2018
Accepted (ET)
Jul 6, 2018 · 8:04 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000921299
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 3, 2018 | M | 7,639 | $2.90 | A | 11,339 | D | |
| Common StockF1 | Jul 3, 2018 | S | 7,639 | $65.00 | D | 3,700 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2 | $2.90 | Jul 3, 2018 | M | 7,639 | D | — | Apr 27, 2020 | Common Stock | 7,639 | 12,000 | D |
Explanation of responses
- F1Shares sold pursuant to a 10b5-1 plan.
- F2Fully vested.